Best Treatment for Multiple Large Kidney Stones
For multiple large renal calculi greater than 2 cm, percutaneous nephrolithotomy (PCNL) should be recommended as first-line therapy, as it provides the highest stone-free rates and lowest retreatment rates compared to all other modalities. 1
Primary Treatment Recommendation
Both the 2026 AUA Guidelines and 2025 EAU Guidelines converge on the same conclusion: PCNL is the gold standard for stones >2 cm (Moderate Recommendation; Evidence Level: Grade B). 1 Meta-analyses consistently demonstrate superior stone-free rates for PCNL versus both shock wave lithotripsy (SWL) and ureteroscopy (URS) in this size range. 1
Why PCNL Over Other Options
SWL should NOT be offered as first-line therapy for stones >2 cm—it has the lowest stone-free rate (18.43% Clavien I-II complications, 2.48% Clavien III-IV), highest retreatment rates (6-9% need auxiliary procedures), and significant risk of steinstrasse (4%) 2, 1
URS has inferior stone-free rates compared to PCNL for large stones, though it remains less invasive 1
Choosing Between Standard vs Mini-PCNL
For Stones 2-3 cm:
Offer mini-PCNL (10-22 Fr) when available, as it provides:
- Comparable stone-free rates to standard PCNL 1
- Fewer Clavien-Dindo Grade 1-2 complications 1
- Less blood loss and lower transfusion rates 1
- Reduced pain and shorter hospital stay 1
- Trade-off: longer operative time 1
For Stones ≥3 cm or Complex/Branched Stones:
Standard PCNL (24-30 Fr) is preferred as it demonstrates higher stone-free rates for larger diameter stones 1. This is particularly important for staghorn calculi where complete clearance is critical. 1
Technical Considerations for PCNL
The 2025 EAU Guidelines provide specific technical guidance 2:
- Positioning: Prone and supine are equally safe; supine allows simultaneous retrograde access
- Puncture guidance: Ultrasound reduces radiation and has lower complication rates than fluoroscopy alone
- Drainage: Tubeless PCNL reduces pain and hospital stay in uncomplicated cases; totally tubeless (no nephrostomy or stent) is effective when no residual stones, bleeding, or infection risk exists
Expected PCNL Complications
From a 12,000-patient review 2:
- Fever: 10.8%
- Transfusion: 7%
- Sepsis: 0.5%
- Mortality: 0.05%
When URS Might Be Considered
URS can be offered as an alternative in highly selected patients who are poor surgical candidates for PCNL or strongly prefer less invasive intervention, but counsel them about:
- Lower stone-free rates (requires average 1.4-1.6 procedures for stones >2 cm) 3, 4
- Best results for stones 2-4 cm (100% stone-free) vs >4 cm (67% stone-free) 4
- Staged procedures are typically necessary 3, 5
- Emerging suction-assisted URS shows promise but insufficient high-quality data for definitive recommendation 1
Critical Pitfalls to Avoid
Do not use SWL for stones >2 cm—unacceptably low stone-free rates and high retreatment burden 1
Screen for untreated UTI before any procedure—absolute contraindication for both PCNL and URS 2
Manage anticoagulation carefully if PCNL is planned 2
For multiple stones: Multi-tract PCNL is safe, feasible, and cost-effective with higher single-procedure stone clearance than flexible URS or SWL 6
Consider stone composition: Struvite/staghorn stones particularly benefit from aggressive PCNL monotherapy 7